Who funded Neuralink? Who is Neuralink designed for?

Neuralink is a company that aims to develop brain-computer interfaces (BCIs) that can help people with neurological disorders or enhance human capabilities. The company was founded in 2016 by Elon Musk and a team of scientists and engineers.

Neuralink has received funding from various sources, including Musk himself, who contributed $100 million of the $158 million raised by July 2019. The company has also attracted investments from venture capital firms such as Founders Fund, Vy Capital, Google Ventures, Valor Equity Partners, and Gigafund.

In July 2021, Neuralink announced a Series C funding round of $205 million, led by Vy Capital. Neuralink’s initial goal is to create devices that can treat serious brain diseases, such as Parkinson’s, Alzheimer’s, epilepsy, and spinal cord injuries.

The company hopes to eventually enable human enhancement by allowing people to communicate with machines, access information, or augment their senses and abilities. Neuralink’s devices are designed to be minimally invasive and compatible with existing medical standards.